【相关性分析何首乌肝毒性成分】
何首乌的肝毒性分析及炮制减毒

何首乌的药理作用
何首乌具有滋补肝肾、益精血、乌须发等作用,常用于治疗肝肾两虚、精血不足 等症状。
何首乌还具有降血脂、抗衰老、抗氧化等多种药理作用,被广泛用于心脑血管疾 病的预防和治疗。
何首乌的毒性作用
何首乌在临床上使用过量或长期使用可导致肝毒性,表现 为肝功能异常、黄疸、肝区疼痛等症状。
此外,何首乌的炮制方法不当也可能增加其肝毒性,因此 需要采取合理的炮制方法以降低其毒性。
何首乌的肝毒性分析及炮制 减毒
2023-11-08
目录
• 何首乌概述 • 何首乌肝毒性分析 • 何首乌炮制减毒研究 • 何首乌安全性评价与展望 • 结论
01
何首乌概述
何首乌简介
何首乌是一种多年生的缠绕藤本植物,其块根可入药,被广 泛应用于中医临床。
何首乌的产地主要分布于中国的华东、中南和西南等地,具 有较高的药用价值。
方法和药物减毒技术,为临床安全使用何首乌提供更加可靠的依据。
05
结论
主要观点与结论
何首乌具有肝毒性,但经过炮制后可降低毒性。 何首乌的肝毒性主要与其所含的蒽醌类化合物有关。
炮制过程中可以改变何首乌中蒽醌类化合物的含量和组成,从而降低其肝毒性。
研究不足与展望
目前对何首乌肝毒性的研究还 不够深入,需要进一步探讨其 作用机制和影响因素。
用药剂量
长期或过量使用何首乌可能导致肝毒性加重 。
联合用药
与其他药物或食物联合使用,可能产生相互 作用,增加肝毒性。
肝毒性预防措施
严格控制用药剂量和用药时间,遵循 医嘱使用。
定期检查肝功能,及时发现并处理肝 脏异常情况。
避免与其他药物或食物联合使用,特 别是可能对肝脏有损害的药物和食物 。
何首乌相关肝毒性的机制研究进展

何首乌相关肝毒性的机制研究进展
李妍怡;张玉杰;汪祺;马双成
【期刊名称】《中国药物警戒》
【年(卷),期】2022(19)6
【摘要】目的分析探讨何首乌肝毒性作用机制及肝毒性物质基础。
方法通过查阅何首乌文献对肝毒性机制和争议成分相关报道进行整理、分析、归纳。
结果何首乌的肝毒性具体表现在影响肝脏代谢酶的功能与表达、使胆汁代谢循环及转运蛋白的功能受阻、以及免疫应激与线粒体功能紊乱等,文献报道其可能的毒性成分为脂溶性蒽醌类、特征性二苯乙烯苷类、鞣质类和二蒽酮类化合物,推测上述物质对机体的单独或协同作用可能与肝毒性发生有关。
结论何首乌肝毒性机制可能众多,相关研究可为何首乌现代研发和安全运用奠定理论基础。
【总页数】5页(P605-609)
【作者】李妍怡;张玉杰;汪祺;马双成
【作者单位】北京中医药大学中药学院;中国食品药品检定研究院
【正文语种】中文
【中图分类】R961;R969.3
【相关文献】
1.中药何首乌肝毒性物质基础及其毒性机制研究
2.何首乌毒性物质基础及肝毒性机制研究进展
3.何首乌肝毒性的物质基础、毒性机制与防控策略
4.基于二相代谢酶
探讨何首乌肝毒性风险及其发生机制5.何首乌对于肾虚模型大鼠肝毒性机制的实验研究
因版权原因,仅展示原文概要,查看原文内容请购买。
何首乌致重度肝功能损伤1例

何首乌致重度肝功能损伤1例摘要本文报道1例何首乌致重度药物性肝炎,患者,男,34岁,以“尿黄、纳差2月”为主诉入院,肝功能示:总胆红素(TBil)368.96 μmol/L,直接胆红素(DBil )290.84 μmol/L,谷丙转氨酶(ALT)1621 U/L,谷草转氨酶(AST)1234 U/L,经保肝、降酶、退黄治疗,患者肝功能检测接近正常水平、肝脏功能基本恢复。
关键词何首乌;中毒;肝功能损伤何首乌是蓼科植物何首乌的干燥块根,根据炮制方法不同,何首乌分为生何首乌和制何首乌。
生首乌具有解毒、消痈、截疟、润肠通便的功效;制首乌主要用于补肝肾、益精血、乌须发、强筋骨、化浊降脂[1]。
随着何首乌及其制剂在临床上的广泛应用,其潜在的不良反应逐渐引起人们的关注,本文报告1例何首乌致严重肝功能损害的典型病例。
1 病例资料1. 1 主诉患者,男,34岁,因“尿黄、纳差2月”于2014年2月11日收入院。
1. 2 现病史患者于2个月前无明显诱因出现上腹部不适,进食后加重,伴食欲下降及进食减少,进食量约为平素一半左右,厌油,角膜黄染,小便赤黄,进行性加重,患者未加以重视。
患者发现全身黄染,遂来本院就诊。
门诊检查结果示TBil 368.96 μmol/L,DBil 290.84 μmol/L,ALT 1621 U/L,AST 1234 U/L,遂以“肝功能损害待查”收入本院消化内科。
患者发病以来,精神、睡眠可,纳差,小便赤黄,体重无明显变化。
1. 3 既往史否认病毒性肝炎及结核等传染病史,否认外伤及重大手术史,无输血及血液制品史,预防接种随当地进行。
否认药物过敏史。
为治疗斑秃,患者于入院前2个月开始应用何首乌(制首乌、生首乌不详),何首乌粉2勺加水冲服,1~2次/d。
1. 4 体格检查神志清,精神可。
查体体温(T)37.6℃,脉搏(P)97次/min,呼吸(R)21次/min,血压(BP)127/76 mm Hg(1 mm Hg=0.133 kPa),全身皮肤黏膜重度黄染,未见蜘蛛痣及肝掌,浅表淋巴结未触及。
中药何首乌肝毒性物质基础及其毒性机制研究

中药何首乌肝毒性物质基础及其毒性机制研究
方文君;谭兴起;胡永胜;施雯宇
【期刊名称】《海峡药学》
【年(卷),期】2015(27)6
【摘要】何首乌是蓼科蓼族何首乌属多年生缠绕藤本植物,有多种药理作用,是临床上应用广泛的一味传统中药.但近年其引起的肝毒性报道不断增多,引发临床的广泛关注.本文从何首乌引起肝毒性的物质基础、临床特点、病理学基础和肝毒性发生机制几个方面进行综述,以便为何首乌临床安全用药和科学研究提供更多方法和依据.
【总页数】3页(P41-43)
【作者】方文君;谭兴起;胡永胜;施雯宇
【作者单位】中国人民解放军第118医院温州325000;中国人民解放军第118医院温州325000;中国人民解放军第118医院温州325000;中国人民解放军第118医院温州325000
【正文语种】中文
【中图分类】R282.71
【相关文献】
1.肝毒性中药及其与药性和有效成分的关系--对55种中药肝毒性文献资料的分析报告 [J], 宋秉智;施怀生
2.何首乌毒性物质基础及肝毒性机制研究进展 [J], 于瑞丽; 门伟婕; 周昆; 于英莉
3.HPLC指纹图谱评价何首乌和制何首乌不同提取部位肝毒性 [J], 许晓丽; 任晶; 翟文泽; 罗兰; 王淑美; 梁生旺; 陈超
4.何首乌肝毒性的物质基础、毒性机制与防控策略 [J], 林艳;李亚梅;吴萍;夏伯候;林丽美;廖端芳
5.抑制CYP2E1增强何首乌水提物肝毒性作用及其毒性成分筛选研究 [J], 胡英还;王子建;李登科;全正扬;王呈谕;孙震晓
因版权原因,仅展示原文概要,查看原文内容请购买。
何首乌致肝损害13例临床分析

论著何首乌致肝损害13例临床分析Ξ杨兴祥,江 南,林建梅△(四川省人民医院感染科,四川成都610072) 【摘要】 目的 回顾性分析何首乌所致肝损害13例临床特征。
方法 收集2005年4月~2007年7月收治的何首乌所致的肝损害13例,详细记录每例患者服药史、临床表现、肝功能、凝血酶原时间、肝炎标志物检查、自身免疫相关检查、影像学检查、治疗经过及预后。
结果 何首乌所致的药物性肝损害潜伏期为7~30d,主要临床表现为乏力、纳差、皮肤巩膜黄染,2例伴有皮肤瘙痒,肝大5例,脾大3例,腹水1例;肝功能酶学明显升高,以A LT升高为主,9213%(12/13)伴有黄疸,以直接胆红素升高为主,重症药物性肝损害2例。
结论 何首乌所致药物性肝损害服药史较隐蔽,多数伴有黄疸,临床分型为混合型,本病预后较好。
【关键词】 何首乌;药物性肝损害;临床分析 【中图分类号】 R57511 【文献标识码】 A 【文章编号】 100420501(2008)1221619202 Clinical analysis of13p atients with liver disease induced polygonum multiflorum thumb.Y ANG Xing2xiang,JIANG Nan,LINJian2mei.Department o f Infectious Disease,Sichuan Provincial People’s Hospital,Chengdu,Sichuan610072,China 【Abstract】 Objective T o investigate clinical character of13patients with liver disease induced polyg onum multiflorum thumb retrospectively.Methods The every patient’s data,including administration history,clinical manifestations,liver function,prothrombin time,hepatitis virus markers,examination of autoimmunity disease,imaging outcome,treatment and prognosis,were recorded in detail from May2005to July2007.R esults The incubation was7~30days.The m ost patients showed hypodynamia,decreased food appetite,skinand icteric sclera.2patients of them accom panied itch of skin.hepatauxe and splenomegaly were5patients and3patients respectively.1 patiet showed ascites.The aminotrans ferase of all patients raised up obviously.A LT was higher than AST.Jaundice was observed by92.3%(12/13)and direct bilirubin raised m ore than indirect bilirubin.severe liver disease induced drug occurred in2patients.Conclusion I t is difficult to discover oral administration history of liver disease induced polyg onum multiflorum thumb.Clinical classification of the disease is mixed type.In spite of occurring m ostly jaundice,its prognosis was g ood.【K ey w ords】 polyg onum multiflorum thunb;liver disease induced drug;clinical analysis 何首乌(polyg onum multiflorum thunb)是一味传统中药,具有广泛的药理作用和临床用途,主要用于滋补肝肾、益精血、乌须发、强筋骨等功效[1]。
对何首乌伤肝的看法

如对您有帮助,可购买打赏,谢谢
对何首乌伤肝的看法
导语:前些时候在门诊给一位女患者开了治疗白发的处方,这位细心患者将处方中所有药在网上查有什么副作用,其中方中有制何首乌15克,二次回来便大
前些时候在门诊给一位女患者开了治疗白发的处方,这位细心患者将处方中所有药在网上查有什么副作用,其中方中有制何首乌15克,二次回来便大叫起来,你给我开的何首乌会引起人体肝脏损害的,如果我服你的药后化验有肝脏损害,你要负完全责任。
我就耐心的做了如下解释:
一、何首乌的副作用
何首乌具有一定的毒副作用,其毒副作用主要是因为何首乌含有毒性成分蒽醌类,如大黄酚,大黄素,甲醚等,如服用量过大对胃肠产生刺激作用,出现肠鸣,恶心,腹痛,腹泻,呕吐等症。
重者可出现阵发性强直性痉挛,躁动不安,抽搐,甚至发生呼吸麻痹。
生首乌是不能长期大剂量使用的,长期大剂量使用容易引起了人体的肝脏损害,出现了转氨酶或胆红素增高,临床出现腹胀、腹泻、恶心、厌食等症状,如果发现有这种情况就需尽早停药了。
二、何首乌的用药禁忌有哪些?
何首乌的在临床使用有生用和制用之分。
生用是指使用未经炮制的何首乌,制用则是指将何首乌按照一定的炮制方法加工后再使用。
未经炮制的何首乌即生首乌,生首乌有解毒、润肠通便的效果;经过炮制的何首乌即制首乌,制首乌具有补肝肾、益精血、乌须发、强筋骨、化浊降脂的功效,主要用于血虚萎黄、眩晕耳鸣、须发早白、腰膝酸软、肢体麻木、崩漏带下、高脂血症等。
究竟应该用生首乌还是制首乌,要根据不同症候和症状特点辨证使用。
常识分享,对您有帮助可购买打赏。
何首乌中二蒽酮类成分肝毒性研究

活性分析·代谢分析何首乌中二蒽酮类成分肝毒性研究*汪祺1,戴忠1,张玉杰2**,马双成1**(1.中国食品药品检定研究院,北京100050;2.北京中医药大学,北京100102)摘要 目的:以胆红素代谢过程中UDP-葡萄糖醛酸转移酶1A1(UGT1A1酶)介导的胆红素葡萄糖醛酸结合环节为切入点,考察何首乌中二蒽酮及蒽酮糖苷成分的肝毒性。
方法:以胆红素为UGT1A1酶底物,以表观抑制常数Ki为评价指标,采用体外大鼠肝微粒体孵育法测定待测单体成分肝毒性有无及大小,并寻找构效关系。
结果:待测单体成分在大鼠肝微粒体(RLM)体系中对UGT1A1酶的抑制由强至弱的顺序为:顺式- 大黄素-大黄素二蒽酮(强抑制),反式-大黄素-大黄素二蒽酮(强抑制),polygonumnolide C2(强抑制),polygonumnolide C3(中等强度抑制),polygonumnolide C4(弱抑制),且存在构效关系,推测6(6′)- 羟基为活性必需基团,其空间暴露程度可影响其与UGT1A1酶的结合,导致不同程度的抑制作用。
结论:本实验初步探讨了何首乌中二蒽酮类成分潜在肝毒性的作用机理,为研究毒性中药提供了新的思路。
关键词:何首乌;二蒽酮;肝毒性;UDP-葡萄糖醛酸转移酶1A1;代谢酶;大鼠肝微粒体;表观抑制常数;中药安全性中图分类号:R 917 文献标识码:A 文章编号:0254-1793(2018)02-0268-07doi:10.16155/j.0254-1793.2018.02.11Study on the hepatotoxicity of dianthrones inPolygoni Multiflori Radix*WANG Qi1,DAI Zhong1,ZHANG Yu-jie2**,MA Shuang-cheng1**(1. National Institutes for Food and Drug Control,Beijing 100050,China;2. Beijing University of Chinese Medicine,Beijing 100102,China)Abstract Objective:To study the hepatotoxicity of dianthrones in Polygoni Multiflori Radix on the basis of the bilirubin metabolism mediated by glucuronidation of UDP-glucuronosyltransferases 1A1 (UGT1A1 enzyme).Methods:Using bilirubin as the UGT1A1 enzyme substrate and the apparent inhibition constant Ki as the evaluation index,the hepatotoxicity was tested by adding the monomers into the rat liver microsomes.And the structure-activity relationship (SAR) was investigated.Results:The order of the inhibition of UGT1A1 enzyme in the system of rat liver microsomes(RLM)was as follows:cis-emodin dianthrones(strong inhibition),trans-emodin dianthrones (strong * 国家自然科学基金(81503347) ** 通信作者 张玉杰 Tel:(010)84738618;E-mail:zhyj226@ 马双成 Tel:(010)67395272;E-maiL:msc@ 第一作者 Tel:(010)67395282;E-maiL:sansan8251@inhibition),polygonumnolide C2(strong inhibition),polygonumnolide C3(moderate inhibition),polygonumnolide C4(weak inhibition).And structure-activity relationship was found.It was presumed that the 6 (6′)-position hydroxyl group was an active and necessary group,whose spatial exposure directly affected the combination with UGT1A1 enzyme to induce different inhibition.Conclusion:The mechanism of potential hepatotoxicity of dianthrones in Polygoni Multiflori Radix was discussed in this study,thus providing a new idea for the study of toxic traditional Chinese medicine.Keywords:Polygoni Multiflori Radix;dianthrones;hepatotoxicity;UDP-glucuronosyltransferases 1A1;metabolic enzymes;rat liver microsome;apparent inhibition constant;safety of traditional Chinese medicine何首乌为蓼科植物何首乌的块根;其味苦,甘,涩,性微温,归肝、肾经,是临床常用的补益药,临床应用有生何首乌与制何首乌之分。
何首乌2(25-49)1982-2012年肝毒性病例分析

赖性和时间依赖性,低剂量的何首
乌提取物并没有肝脏损伤的作用,
甚至还有一定的肝脏保护作用,然
而随着剂量的升,何首乌的肝脏保
NA
首次发生
。无“肝炎”患者密 首次发生 切接触史。病前半年 内无输血及血制品应 用史。有在外就餐, 近期有进食海鲜史。 无伤寒、猩红热等传 染病史,无“心、脑 、肺、肾”等脏器慢 性病史,无外伤史, 无药物及食物过敏史
1
、49
(女)
35
2008
13 男5女 32-68 乌发及治疗脱发6 例, 治
8
疗失眠2 例, 用于耳鸣、
降血压、腿膝无力、性功
能减退及皮肤病各1 例
36
2000-2008 9 男6女 34-68 8例为治白发、脱发,1例
年收治
3
为治偏瘫
37
2009
1 女 31
产后大便不畅
38
2009
1 女 54
首乌片(炮制品) 单味
18片/d
30-40d
54岁者因巩膜及全身皮 肤粘膜黄染十余日入 院.26岁者因食欲不振、 恶心、尿黄9 d入院.
饮片(炮制品),水 复方(组方 NA
18d
体检时肝功能异
煎
不明)
首乌丸
复方
12g/d
45d
乏力、纳差、食欲不振
、厌油、尿黄、皮肤、
巩膜黄染
饮片(生品),水煎 38岁者单 38岁者30g/d; 味;51岁者 51岁者15g/d 复方
除1例HBS一Ab阳性 2例2次发生;3例3次 浙江余姚
(有明确乙肝疫苗接 发生;4例3例发生
种史)外,均为阴性;
血清各种自身抗体检
测均为阴性。
无肝病史
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Journal of Hazardous Materials 299(2015)249–259Contents lists available at ScienceDirectJournal of HazardousMaterialsj o u r n a l h o m e p a g e :w w w.e l s e v i e r.c o m /l o c a t e /j h a z m atA novel method to analyze hepatotoxic components in Polygonum multiflorum using ultra-performance liquidchromatography-quadrupole time-of-flight mass spectrometryLongfei Lin a ,Hongmei Lin a ,Miao Zhang a ,Boran Ni b ,Xingbin Yin a ,Changhai Qu c ,Jian Ni a ,∗aSchool of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing,China bSchool of Basic Medical Science,Beijing University of Chinese Medicine,Beijing,China cModern Research Center for TCM,Beijing University of Chinese Medicine,Beijing,Chinah i g h l i g h t s•Investigated the hepatotoxicity ofPolygonum multiflorum and its con-stituents.•The run time of each sample was 25min by UPLC-Q-TOF/MS.•Used an analytical method based on Progenesis QI and Makerlynx XS soft-ware.•Identified 9potential hepatotoxic components in P.multiflorum.g r a p h i c a la b s t r a cta r t i c l ei n f oArticle history:Received 17March 2015Received in revised form 21May 2015Accepted 6June 2015Available online 9June 2015Keywords:Polygonum multiflorumPolygonum multiflorum Praeparata Hepatotoxicity ToxicityUPLC-Q-TOF/MSa b s t r a c tPolygonum multiflorum ,called Heshouwu in China,is a traditional Chinese medicine used to treat var-ious diseases .However,the administration of P.multiflorum (PM)and P.multiflorum Praeparata (PMP)causes numerous adverse effects.This study sought to analyze the toxic components of PM using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS),and their hepatotoxicity in L02human liver cells.Toxicity was evaluated by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),lactate dehydrogenase (LDH)leakage,and liver enzyme secretion (aspartate aminotransferase [AST]and alanine aminotransferase [ALT])assays.Furthermore,UPLC-Q-TOF/MS,Progenesis QI,and Makerlynx XS software analyses were used to differentiate extracts and analyze the toxic components.The order of toxicity was P.multiflorum ethanol extract (PME)>P.multiflorum water extract (PMW)>P.multiflorum Praeparata ethanol extract (PMPE)>P.multiflorum Praeparata water extract (PMPW),which was determined by MTT assay,LDH leakage,and liver enzyme secretion levels.The analysis methods suggest that PM toxicity may be associated with anthraquinone,emodin-O -(malonyl)-hex,emodin-O -glc,emodin,emodin-8-O -glc,emodin-O -(acetyl)-hex,and emodin-O -hex-sulphate.The toxic mechanisms of these components require further study.©2015Elsevier B.V.All rights reserved.∗Corresponding author.Fax:+861084738607.E-mail address:njtcm@ (J.Ni).1.IntroductionPolygonum multiflorum is a popular traditional Chinese medicine used in many patent medicines and prescriptions.Recent stud-ies showed that PM has antioxidant activity,due to its flavonoid/10.1016/j.jhazmat.2015.06.0140304-3894/©2015Elsevier B.V.All rights reserved.250L.Lin et al./Journal of Hazardous Materials299(2015)249–259Table.1The dried extract rate and diluted concentrations of different extracts.Name Dried extract rate(%)Concentrations for cell tests(g/mL)PME29.201000.00704.00352.00176.0088.0044.0022.0011.00 PMW35.601000.00859.00429.5214.75107.3853.6926.8413.42 PMPE20.681000.00500.00250.00125.0062.5031.2515.637.81 PMPW41.441000.00500.00250.00125.0062.5031.2515.637.81and phenolic acid compounds[1].Additionally,stilbene from PM has anti-tumor,anti-aging,and liver-protective effects[2,3]. Furthermore,anthraquinones have many biological effects,includ-ing antimicrobial,antioxidant,and antihuman cytomegalovirus activity[4].However,researches have reported PM-induced hepa-totoxicity,nephrotoxicity,and embryonic toxicity.Hepatic adverse events,including acute toxic hepatitis,have been reported in many countries[5–9].PM also induces nephrotoxicity[10,11].Emodin, rhein,and physcion,the major components of PM,significantly inhibit the proliferation of a human proximal tubular epithelial cell line(HK-2)[12].Moreover,PM can also induce lung toxicity[13].Although PM toxicity is of great concern,the hepatotoxic com-ponents remain unknown.In this study,the toxicity of water and ethanol extracts from PM and PMP wasfirstly compared.Secondly, the components in these four extracts were comprehensively ana-lyzed by UPLC-Q-TOF/MS,tofind out the variation tendency of the components in these four extracts based on Progenesis QI and Makerlynx XS software.Thirdly,the toxic components in PM were speculated through the combination of the toxicity results and data analysis.The well-designed experiments in vitro to predict the toxi-city induced by risky material and medicine foe humans.MTT assay is the most common method for detecting cell growth and survival, and it is also widely used to evaluate the cytotoxicity.So,the toxi-city induced by PM and PMP was investigated on human liver cells (L-02)in vitro in this study,and used a novel analytical method to analyze the toxic components.2.Materials and methods2.1.ChemicalsMethanol(HPLC-grade)was purchased from Fisher Scientific (Waltham,MA,USA).HPLC-quality water was obtained from a Cascada TM IX-water Purification System(Pall Co.,Port Washing-ton,NY,USA).Ammonia was purchased from Guangdong Xilong Chemical Co.,Ltd.(Shenzhen,China).PM and PMP were provided by Beijing Tongrentang Co.,Ltd.(Beijing,China).Standard samples of emodin and2,3,5,4 -tetrahydroxystilbene-2-O--glucoside were purchased from Shanghai Standard Biotech Co.,Ltd.(Shanghai,China).Emodin-8-O--d-glucopyranoside,cat-echin,l-epicatechin,P-hydroxybenzaldehyde,rhaponiticin,and gallic acid were purchased from Shanghai Yuanye Bio-Technology Co.,Ltd.(Shanghai,China).2.2.Preparation of P.multiflorum extractsPM and PMP were decocted three times with10-fold water or 70%ethanol for1.5h.The resultingfiltrates were mix together and concentrated to dryness under reduced pressure.The dried extract rate of each extraction was shown in Table1.The concentrations of the major components were displayed in Supplementary data 1.The stock solutions for the cellular evaluations were made by dissolving the extracts in50%dimethylsulfoxide(DMSO).Extracts were further diluted with0.2%fetal bovine serum(FBS,Hyclone, Logan,UT,USA)in Dulbecco’s modified Eagle’s medium(DMEM, Gibco Invitrogen Corp.,Grand Island,NY,USA)to the concentra-tions shown in Table1.The diluted concentrations of the different extracts were not same with each other,because the purpose is to ensure the quantity of the crude herbs was equivalent,allowing for the comparison of extract toxicity.For example,704g/mL of PME,859g/mL of PMW,500g/mL of PMPE,and1000g/mL of PMPW contained the same quantity of crude herbs.In this section, the diluted manner was different from previous studies,because we are not only to obtain the IC50of each extracts,but also to make a parallel-group study to compare the hepatotoxicity(ALT,AST and LDH)about these four extracts at the same amount of crude herbs.2.3.Culture conditionsL02cells,a human-derived fetal hepatocyte cell line,were pur-chased from China Infrastructure of Cell Line Resources.Cells were cultured in DMEM supplemented with10%FBS.Cultures were maintained in a humidified incubator with5%CO2and95%air at 37◦C.Trypsin(0.5%,Sigma,St.Louis,MO,USA)was used to passage cells at80–90%confluence.2.4.MTT cell viability assayThe MTT reduction assay was used to determine cell viability. The L02cells were seeded into96-well plates(1×104cells/well, Corning Incorporated,Corning,NY,USA)and incubated for24h. And then,cells were exposed to fresh medium with various extract concentrations for36h.Following incubation,5mg/mL of MTT (10L,BioTOP,Suzhou,China)dissolved in PBS(pH7.4)was added and incubated for4h.The medium was then removed,and100L of DMSO was added to dissolve the formazan product.Crystals were dissolved in DMSO after gently swirling the96-well plates for 5min at room temperature.The absorbance change of specimen was measured under570nm using a Multiskan GO spectrometer (Molecular Devices,Thermo,Waltham,MA,USA).2.5.Enzyme leakage from L02cell after extract treatmentThe activity of the AST,ALT,and LDH releasing,were regarded as the index of hepatotoxicity.L02cells were seeded in24-well plates(2×104cells/well,Corning Incorporated).After24h,cells were exposed to fresh medium with the test compounds or extrac-tions for36h.The Culture medium was then analyzed for AST,ALT and LDH using a kit(Beijing Leadman Biochemistry Co.,Ltd.,Bei-jing,China)on the Glamour4000biochemical analyzer(Glamour Co.,Ltd.,USA).Six plates were read in parallel,with4wells per condition.2.6.UPLC-Q-TOF/MS analysis of PME,PMW,PMPE and PMPW2.6.1.Sample preparationThe PME,PMW,PMPE and PMPW samples(365.1,445.0,258.3, and518.1mg,respectively)were accurately weighed respectively for6times.The PMW and PMPW were dissolved in50mL of water, and the PME and PMPE were dissolved in50mL of70%ethanol. Varying concentrations were diluted to1mL.Then,they were cen-trifuged at14,000rpm for10min to separate the supernatant for UPLC-Q-TOF/MS analysis.L.Lin et al./Journal of Hazardous Materials299(2015)249–259251 Table.2MTT assay results for PME,PMW,PMPE and PMPW.PME PMW PMPE PMPWg/mL Cell proliferation(%)g/mL Cell proliferation(%)g/mL Cell proliferation(%)g/mL Cell proliferation(%)11.0095.16±11.1313.42100.93±5.137.8198.58±3.707.81100.85±2.4522.0097.58±8.4926.8496.87±4.4715.6397.65±13.2615.63101.21±0.9444.00101.00±9.8053.6997.08±5.9331.2594.16±2.7031.2599.86±10.8488.0087.04±25.54107.3895.09±4.9162.5088.46±2.3462.5099.00±8.41176.0082.26±4.64214.7594.37±5.52125.0089.46±0.89125.0097.86±12.70 352.0042.31±3.39429.5068.95±6.72250.0078.42±3.67250.00103.77±6.33 704.0011.47±0.63859.0020.58±1.85500.0073.22±5.28500.00101.42±5.671000.008.62±1.281000.0020.16±0.631000.0056.20±6.621000.0086.89±4.50Table.3Enzyme secretion of AST,ALT and LDH from L02cell after exposure of PME,PMW,PMPE and PMPW.Group AssayPME Concentration(g/mL)1000.00703.00351.50175.7587.8843.9421.9710.98Control AST(U/L)23.08±9.27***21.10±4.85**15.85±0.8313.98±2.8113.38±2.6414.03±1.1512.00±2.3314.60±0.4514.11±2.84 ALT(U/L)10.65±3.25*** 6.85±1.14*** 4.43±0.41** 3.03±0.83 2.65±0.88 2.10±0.55 2.30±0.92 2.20±2.03 2.01±0.54 LDH(U/L)62.73±8.37***60.75±11.48***46.45±4.80***39.68±8.02***29.13±1.5923.55±1.5222.98±3.4421.85±6.4022.16±5.52PMW Concentration(g/mL)1000.00916.00458.00229.00114.5057.2528.6214.31 AST(U/L)21.50±2.40***17.93±1.70*15.13±1.8014.15±2.0711.70±2.1912.50±1.2713.08±3.8611.48±3.0714.11±2.84 ALT(U/L)7.23±2.99*** 5.25±0.99*** 3.90±0.57** 2.30±0.48 2.20±0.59 2.00±0.41 1.90±0.42 2.20±0.43 2.01±0.54 LDH(U/L)55.05±4.78***56.73±0.57***40.63±7.04***30.13±3.13*23.23±4.5521.85±2.2420.58±2.9315.93±5.7422.16±5.52 PMPE Concentration(g/mL)1000.00500.00250.00125.0062.5031.2515.637.81 AST(U/L)15.48±3.5715.08±3.6614.18±0.7712.50±1.6812.03±2.4812.98±0.9312.40±3.0612.33±1.9714.11±2.84 ALT(U/L) 4.05±1.75*** 2.85±1.18 2.78±0.71 2.10±0.32 2.10±1.31 2.05±0.66 1.75±0.71 2.05±0.52 2.01±0.54 LDH(U/L)44.25±2.30***37.38±2.40***31.25±2.22**23.90±4.8419.58±4.4322.13±7.8621.48±2.5722.40±3.2422.16±5.52PMPW Concentration(g/mL)1000.00500.00250.00125.0062.5031.2515.637.81 AST(U/L)15.90±2.5114.63±2.9915.90±2.0913.50±1.5113.53±1.4414.63±1.0114.13±2.6614.10±1.1614.11±2.84 ALT(U/L) 3.30±1.21* 2.08±0.40 2.13±0.54 2.15±0.90 2.13±0.28 2.00±0.98 1.85±n0.72 2.15±0.96 2.01±0.54 LDH(U/L)31.78±4.21**24.33±5.7824.93±3.9521.28±3.0021.83±1.5722.93±6.9322.85±3.9319.45±2.6622.16±5.52*,**,***Significant difference compared with control cells,p<0.05,p<0.01,p<0.001.2.6.2.Chromatographic and mass spectrometric conditionsAnalysis was performed on a Waters Acquity Ultra Performance LC system coupled with a Xevo G2Q-TOF mass spectrometry equipped with an electrospray ionization(ESI)source(Waters Corp.,Milford,MA,USA).The separation of all samples was per-formed on an ACQUITY UPLC HSS T3(100×2.1mm,1.8m).The gradient elution employed0.1%of formic acid-acetonitrile solu-tion as solvent A and0.1%of formic acid aqueous solution as solvent B.The gradient program was as follows:0–3min,0–10%A; 3–10min,10–20%A;10–20min,20–70%A;20–21min,70–100% A;21–21.1min100–0%A;21.1–25min0%A.Theflow rate was set at0.3mL/min,the injection volume was5L.Negative ion ionization was used for the detection of more com-pounds and it had higher sensitivity than the positive mode[14]. The cone gas and the source temperature were set to50L/h and 120◦C.The capillary was2.5kV.High-purity nitrogen served as both the nebulizing and dry gas.The desolvation temperature was held at350◦C,and the gasflow was600L/h.The full-scan range was from50to1200m/z.The validation of the UPLC-Q-TOF/MS method was displayed in Supplementary data2.2.7.Statistics and DATA analysisAll cytotoxicity data were expressed as the mean±SD.The data were subjected to one-way analysis of variance(ANOVA)fol-lowed by multiple group comparisons test,and were calculated by using the Probit function in SPSS17.0.The half-maximal inhibitory concentration(IC50)of each tested compound or extraction was cal-culated with GraphPad prism5.Results were classified into three significance levels using the p-values0.05,0.01,and0.001.The LC–MS runs were loaded on Progenesis QI software,which can visualize the raw data at each step in the analysis without missing values.Ion intensity maps shows a2D representation of retention time,m/z,and feature intensity,as well as mass spectra and chromatogram views,provided quality assurance of the auto-matic alignment,peak picking,and compound deconvolution on every run.Wefiltered the data as necessary,and then imported into Makerlynx XS software to analyze.3.Results and discussion3.1.Extract toxicityIn order to evaluate the hepatotoxicity of PM and PMP,more than one assay should be used to determine cell viability in vitro, in order to increase the reliability of the results.The MTT and LDH assays reflect the proliferation and the function of cell membranes. In contrast,the ALT and AST activity levels are the important indi-cator of hepatotoxicity.The ALT level is3times greater than normal indicate liver injury[15,16].Changes in cell proliferation after PME,PMW,PMPE and PMPW exposure are listed in Table2.The AST,ALT and LDH levels are shown in Table3.PME showed significant cytotoxicity and hepatotoxicity,inhibit-ing cell growth57.69%at352g/mL and88.53%at704g/mL,as determined by MTT assay.LDH leakage was elevated significantly following the176g/mL treatment.ALT leakage was significantly increased in the352and704g/mL groups.Furthermore,the ALT and LDH levels were3times higher than those in the control group after the704g/mL treatment.PMW cytotoxicity was weaker than PME.Cell survival rates after PMW treatment were higher than the rates in MTT assay,with 31.05%and79.42%inhibition at429.5and859g/mL,respectively.252L.Lin et al./Journal of Hazardous Materials299(2015)249–259Table.4The constituents detected in PME by UPLC-Q-TOF/MS.No.t R[M-H]−or[M+FA-H]−Error(ppm)Formula Identification10.889227.03214C8H9N2O9Unknown20.941195.0508 1.5C6H11O7Gulonic acid3 1.0311025.3427 1.9C36H65O33Trehalulose4 1.065341.1082/683.2263−0.6C12H21O11Glucosyl-glucose5 1.065404.1038−0.7C12H22NO14Unknown6 1.116439.0771−1.6C14H19N2O14Unknown7 1.416387.1136−0.8C13H23O13Unknown8 1.433133.0135−1.5C4H5O5Malic acid9 1.454475.12990C16H27O16Unknown10 2.524503.1588−4.8C18H31O16Glucopyranosyl–glucopyranosyl-glucose11 2.579128.03490.8C5H6NO3N-Acryloyl glycine12 2.648191.0187−2.6C6H7O7Citric acid13 3.529169.0132−3C7H5O5Gallic acid14 4.021331.0654−3.3C13H15O10Glucosyl gallate15 4.162419.1667−3.3C22H27O8cis-rhaponitin16 4.179419.1666−4.5C22H27O8Rhaponitin17 6.164531.1502−0.2C26H27O12Unknown18 6.202142.0654−2.1C10H8N Unknown19 6.322531.1499−0.8C26H27O12Unknown20 6.763289.0718 2.1C15H13O6Catechin217.289549.1605−0.5C26H29O13Unknown227.73567.173 2.8C26H31O14Tetrahydroxystilbene-O-di-hex238.312289.0704−2.8C15H13O6l-Epicatechin248.556729.145−0.8C37H29O16Mono-o-galloylprocyanidin258.979405.1184−0.5C20H21O9Tetrahydroxystilbene-O-hex269.172729.1453−0.4C37H29O16Mono-o-galloylprocyanidin279.33729.1454−0.3C37H29O16Mono-o-galloylprocyanidin289.419405.1185−0.2C20H21O9cis-2,3,5,4 -Tetrahydroxystilbene-2-O-glc 299.595729.1446−1.4C37H29O16Mono-o-galloylprocyanidin3010.07421.1145 2.4C20H21O10Catechin-O-furanoside3110.263567.1722 1.4C26H31O14Tetrahydroxystilbene-O-di-hex3210.755567.17140C26H31O14Tetrahydroxystilbene-O-di-hex3311.477405.1197 2.7C20H21O92,3,5,4 -Tetrahydroxystilbene-2-O-glc 3411.863557.12960.2C27H25O13Tetrahydroxystilbene-O-(galloyl)-hex 3512.513557.12960.2C27H25O13Tetrahydroxystilbene-O-(galloyl)-hex 3612.551447.12920.2C22H23O10Tetrahydroxystilbene-O-(acetyl)-hex 3712.727555.11390C27H23O13Unknown3812.988431.0984 1.4C21H19O10Emodin-O-glc3913.129447.1284−1.6C22H23O10Tetrahydroxystilbene-O-(acetyl)-hex 4013.219557.1302 1.3C27H25O13Tetrahydroxystilbene-O-(galloyl)-hex 4113.779312.1245 2.9C18H18NO4N-trans-feruloyl tyramine4213.819551.1559 1.1C36H23O6Tetrahydroxystilbene-2-O-(coumaroyl)-hex 4313.821581.16610.3C30H29O12Tetrahydroxystilbene-2-O-(feruloyl)-hex 4413.869511.05460C21H19O13S Emodin-O-hex-sulphate4513.886431.09810.7C21H19O10Emodin-O-glc4614.078407.1339−0.7C20H23O9Torachrysone-8-O-glc4714.185431.0980.5C21H19O10Emodin-8-O-glc4814.536559.1458 1.1C27H27O13Torachrysone-O-glucogallin4914.75517.0979−0.6C24H21O13Emodin-O-(malonyl)-hex5014.767473.1083−0.2C23H21O11Emodin-O-(acetyl)-hex5115.045283.0604−0.7C16H11O5Anthraquinone5215.383473.10840C23H21O11Emodin-O-(acetyl)-hex5315.486329.2327−0.3C18H33O5Trihydroxy-octadecenoic acid5416.786283.0609 1.1C16H11O5Anthraquinone5517.492283.06−2.1C16H11O5Anthraquinone5618.39269.0445−1.9C15H9O5Emodin5719.515269.0445−1.9C15H9O5Anthraquinone5819.952277.1809 1.8C17H25O3Heptadecanoic acid-ester5920.093329.2326−0.6C18H33O5Trihydroxy-octadecenoic acidThe ALT and LDH leakage also significantly increased at these two concentrations,although to a smaller extent than PME.The toxicity of PMPE was obviously weaker than that of PME and PMW,as the growth inhibition rates were markedly lower. Although the LDH leakage significantly increased with250g/mL treatment,ALT levels were not significantly altered.PMPW did not inhibit cell proliferation in the MTT assay,except where they were at the condition of highest concentration(1000g/mL).The cyto-toxicity and hepatotoxicity of this extract was the lowest in four extracts.In summary,the PME(IC50=345g/mL in the MTT assay), PMWE(IC50=555g/mL),PMPE(IC50=1536g/mL),and PMPW (IC50>10,000g/mL)showed severe,moderate,less and no cyto-toxicity,respectively.The cytotoxicity of PM was stronger than that of PMP,and the ethanol extract exerted greater cytotoxicity than the water extract.Considering that the elevated enzyme secre-tion affects liver function,patients should be monitored during the long-term use of PM.3.2.UPLC-Q-TOF/MS analysis of PMW,PME,PMPW and PMPEIn this study,59major ingredients in PMW,PME,PMPW and PMPE were separated and detected by using a UPLC-Q-TOF/MS system(Table4).49of the59compounds were identified byL.Lin et al./Journal of Hazardous Materials299(2015)249–259253 Table5The difference between every two groups using OPLS-DA.Group1vs Group2m/z Retention time(min)Group1Group2PME vs PMW341.1081 1.36640545738565475.1298 1.435054104482133.0135 1.4290354181835557.129411.86316547201540231.065412.816478812085431.097213.0122276674154245.08114.0872097188886230.05714.0812824717141407.133714.0811********.19431.097714.2223004701118380863.202614.2213853617641.3473.108414.73129229079405.8517.098414.73142514526.5861035.20514.73909360.0015245.081214.81487792117.35283.060415.01665031131789919.229915.05584530.001283.059915.682296227751.92269.044519.5232710051968.1 PMW vs PMPE341.1082 1.03666478161144683.2248 1.0342942932758341.1081 1.3673856561138.8683.2244 1.36213840159531.1497 6.1537316285792531.1499 6.2936169212242243.065711.4439327001883750405.118611.4447948601470430811.245411.44101500099166431.097913.853*********511.054813.852*********.55431.097714.221118380376589269.044519.5251968225075PMW vs PMPW341.1082 1.03666478138351683.2248 1.0342942928648341.1081 1.3673856575162683.2244 1.36213840113133.0135 1.4218183588001503.0854 2.980.0004131238289.0707 6.76154848805405.118611.4447948602098970811.245411.441015*********557.129411.8620154061124.8431.097913.853*********511.054813.852********431.097714.221118380177239269.044818.35223263820PME vs PMPE341.1082 1.03712067161144683.2248 1.0345459832758341.1081 1.3664054561138683.2244 1.36227135159531.1497 6.157806285792531.1499 6.297936212242549.16057.297580170192405.118611.4443458801470430811.245411.4494793899166557.129411.8631654762642431.097913.855261368941511.054813.852*********245.08114.0872097159594431.097714.222300470376589473.108414.7312922901283.88283.060415.01665031104527283.059915.6822962211130293.178118.18150920352149269.044818.3526474112517PME vs PMPW277.03210.897464.06243919341.1082 1.03712067138351683.2248 1.0345459828648341.1081 1.3664054575162503.0854 2.980.0004131238405.118611.4443458802098970811.245411.44947938226532431.097913.855261362604511.054813.852********245.08114.0872097124817254L.Lin et al./Journal of Hazardous Materials 299(2015)249–259Table 5(Continued )Group1vs Group2m /zRetention time (min)Group1Group2431.097714.222300470177239473.108414.731292290182283.060415.0166503135021293.178118.18150920322613269.044818.35264741820269.044519.5232710028539PMPE vs PMPW531.1497 6.1528579293664531.1499 6.2921224273385549.16057.2917019283491531.158.158949542089811.245411.4499166226532431.097714.22376589177239283.060415.0110452735021269.044519.5222507528539595.287620.78132010666712.536321.41756430.003Fig.1.The translation process by Progenesis QI software.the comparison with standards or investigating -pounds 8,15,16,20,25,35,and 47were attributed to gallic acid,rhaponitin,catechin,l -epicatechin,2,3,5,4 -tetrahydroxystilbene-2-O -glc,emodin-8-O -glc,and emodin,respectively,by comparing the retention times and mass spectral data with reference pounds 2and 4were attributed to gulonic acid and glucosyl-glucose,whereas compound 12was identified as citric acid by using references [17].Compound 11was characterized as N -acryloyl glycine [18].Compound 24,26,27,and 29showed the same [M–H]−ions at m /z 729.145,so they may be isomers of mono-o -galloylprocyanidin [14].Compounds 22,25,28,31,32,34,35,36,39,40,42,and 43gave diagnostic ions at m /z 405and 243,suggesting that they are tetrahydroxystilbene-O -hex derivatives.There are four groups of compounds (compounds 22,31,32;com-pounds 25,28;compounds 34,35,40and compounds 36,39)that produced the same [M–H]−ions at m /z 567.17,557.13,and 447.13,indicating they may be isomers of tetrahydroxystilbene-O -di-hex,2,3,5,4 -tetrahydroxystilbene-2-O -glc,tetrahydroxystilbene-O -(galloyl)-hex,and tetrahydroxystilbene-O -(acetyl)-pounds 42and 43were identified as tetrahydroxystilbene-2-O -(coumaroyl)-hex and tetrahydroxystilbene-2-O -(feruloyl)-hex [19–21],pounds 46and 48gave [M–H]−ions at m /z 407.1339(C 20H 23O 9)and m /z 559.1458(C 27H 27O 13),which were torachrysone-8-O -glc and torachrysone-O -glucogallin,respectively.[20]Compounds 44,45,49,50and 52showed [M–H]−ions at m /z 511.0546,431.0981,517.0979,473.1083,and 473.1084,which further yielded the same ions at m /z 431and 269.By investigating the reference data,the compounds were ten-tatively characterized as emodin-O -hex-sulphate,emodin-O -glc,emodin-O -(malonyl)-hex,emodin-O -(acetyl)-hex,and emodin-O -(acetyl)-hex [14,17,22,23].Compounds 51,54,55,and 56showed [M–H]−ions at m /z 283.0604,283.0609,283.06,and 269.0445.These four compounds were anthraquinone constituents;how-ever,they did not match the standards for physcion,rhein,and emodin.Thus,compounds 35,37,and 38may be isomers of physcion,rhein,or pounds 58and 59were lipids in PM,which were identified as heptadecanoic acid–ester and trihydroxy-octadecenoic acid [24].Some components were diffi-cult to identify,because the levels were low in PM.L.Lin et al./Journal of Hazardous Materials299(2015)249–259255Fig.2.The peak picking-ion map.Fig.3.The normalization graphs of the PME,PMW,PMPE and PMPW.256L.Lin et al./Journal of Hazardous Materials 299(2015)249–259Fig.4.OPLS-DA scatter plots of the difference between two groups.A =PME vs PMW;B =PMW vs PMPE;C =PMW vs PMPW;D =PME vs PMPE;E =PME vs PMPW;F =PMPE vsPMPW.Fig.5.The dendrogram of the correlation analysis.3.3.DATA analysis of PMW,PME,PMPW and PMPEIn order to observed all differences among the four extracts,fur-ther sample profiling of the gelatins required the use of multivariate statistical tools.In this study,the first step of the multivariate sta-tistical analysis was to convert the 3D LC/MS data into a 2D matrix,expressed as an Exact Mass Retention Time (EMRT)pair by using Progenesis QI3.3.1.Step 1:DATA analysis by Progenesis QIFirstly,the TIC spectrum (Fig.1A)created by UPLC-Q-TOF/MS for all samples were imported into the Progenesis QI software andL.Lin et al./Journal of Hazardous Materials 299(2015)249–259257Fig.6.The results of presumed toxic components.(Note:m /z at 517and 1035were one compound.407,m /z at 230and 245also were one compound in A.m /z at 863and 431,t R at 14.2,m /z at 473and 245also were one compound in B,respectively).translated into a 2D ion intensity map,as shown in Fig.1B.The ordinate represented the retention time,and the abscissa was m /z .Secondly,six QC samples were evaluated to determine whether all four group samples were aligned.The alignment vector is shown in Fig.1C.The results of the alignment quality evaluation revealed thatthe scores of all samples had scores greater than 90%,as shown in Fig.1D.Not all peaks in the total ion chromatogram (TIC)spectrum represent a single compound,due to high background,chromatog-raphy condition,or sample handling methods.Thus,we set the sensitivity value to three,and the minimum peak width to 0.15min,Fig.7.Suggested method of presumed the toxic ingredients in TCM.258L.Lin et al./Journal of Hazardous Materials299(2015)249–259Table6The constituents selected by correlation analysis.Name No.t R[M-H]−Identification6-A115.68283.0599Anthraquinone215.01283.0604Anthraquinone314.08407.1337Torachrysone-8-O-glc414.73517.0984Emodin-O-(malonyl)-hex6-B513.01431.0972Emodin-O-glc618.35269.0448Emodin713.85431.0979Emodin-O-glc811.86557.1294Tetrahydroxystilbene-O-(galloyl)-hex914.22431.0977Emodin-8-O-glc1014.73473.1084Emodin-O-(acetyl)-hex1113.85511.0548Emodin-O-hex-sulphatethis setting which has been found to give the best balance of detect-ing as many real feature ion signals as possible while detecting as little random noise as possible.Under these conditions,1403 peaks were observed in the2D ion intensity map,as shown in Fig.2.The normalization graphs for the four groups are shown in Fig.3.Although we identified1403compounds in the extracts, not all compounds are targets for our analysis.To identify the rea-sons for the differences in toxicity,we must identify difference in the composition between the four extracts.In order to obtain more accurate results,we included two restriction conditions to choose analytes:an ANOVA p-value≤0.05and a maximum fold change≥2fold change,these two parameter using for selecting significantly changing compounds,setting like these will reduce the“false discovery rate(FDR)”.Under these conditions,1103of the1403compounds satisfy the requirements.Finally,the selected compounds were exported into EZinfo for analysis.3.3.2.Step2:DATA analysis by Makerlynx XSThe data set was visualized by using unsupervised PCA to check for outliers and classification trends among the extracts.In the score plot obtained by PCA,the four extracts were located farther from each other,indicating a clear differentiation between the extracts. The difference between two groups was evaluated by using OPLS-DA.The obtained scatter plots are shown in Fig.4.In the scatter plot, each point represents accurate mass-retention time data.The X-axis represents the variable,and the distance of the data point from the origin indicates the relative contribution.The data at both ends of the S-curve represent the highest credibility characteristic ions of the groups.So,it is suggested tofilter out the significantly dif-ferent variables(Markers)between two groups.These plots clearly display the observations with a high absolute value of p(corr)[1] and a high absolute value of the coefficients.The observations dif-ferentiating between every two groups are listed in Table5.3.3.3.Step3:Correlation analysis the DATAThe differentiated compounds which found in step2were re-imported into Progenesis QI software for correlation analysis,as shown in Fig.5.This analysis correlates with the content of these differentiated compounds in the four extracts.bined results of the toxicity and data analysis to identify toxic componentsAs shown in Fig.6A,upon combining the results of the correla-tion analysis,the compound content inside the box was abundant in PME,but low in the other three extracts.The description of these ingredients is shown in Table6A(Combined the different ions produced by the same compound).This may be the rea-son why the toxicity of PME was stronger than other extracts. Based on the cytotoxicity analysis,the order of extract toxicity was PME>PMW>PMPE>PMPW.The AST,ALT,and LDH leakage also reflected this trend.Furthermore,the results of the correlation anal-ysis(Fig.6B)showed that the levels of the compounds inside the box were consistent with this trend.Characterization of these com-pounds is shown in Table6B(Combined the different ions produced by the same compound).The toxicity of PMPE was stronger than PMPW.The results of the OPLS-DA may explain why PMPE toxic-ity was stronger than PMPW.The analysis revealed11compounds that may be associated with PM hepatotoxicity(Table6).In the investigation of the reference samples,emodin showed severe cytotoxicity in L-02cells,is an important chemical con-stituent that induces liver cell damage[25–28].Our results coincided with these conclusions,as9of the11compounds were anthraquinone or its’derivatives,and7of the9compounds were emodin and its’derivatives,suggesting that PM toxicity may be caused by emodin and its derivatives.The results of the toxic-ity test of emodin showed that emodin has strong cytotoxicity indeed(Supplementary data3).Emodin derivatives are inher-ently toxic,or they produce toxicity by their metabolites,such as emodin,which requires further research.The other two compounds were torachrysone-8-O-glc and tetrahydroxystilbene-O-(galloyl)-hex.However,research regarding these compounds is limited and they require further study.4.ConclusionsPM hepatotoxicity is of great concern;however,the com-ponents that induce hepatotoxicity are unknown.Besides,the present studies also have many contradictions,such as some stud-ies demonstrated that PMW has greater toxicity than other extracts [29,30],but another study considered as PME[31].In this assays,it is proved that the water extractions were less toxic than the70% ethanol extractions which indicated that water decoction was a more rational extractive agent for PM and PMP.Judging from the results,the processing produce could reduce the cytotoxicity of PM to a certain extend.The difference in the toxicity above-mentioned was related to the ingredients differences(both in species and con-tents)in the four extracts.The omics research method,which was based on PCA and OPLS-DA,was introduced into the study.The purpose is tofind out the toxic ingredients instead of biomarkers. Because traditional Chinese medicine(TCM)is complex compo-nents,it is hardly to obtain and research each ingredient in TCM. But,we provide an idea can greatly narrow the scope of the tar-get compounds and also greatly reduce the effort and cost in the research,just shown as Fig.7.Under this method,the results of our data analysis and toxicity study suggest that PMP toxi-city may be related to anthraquinone,emodin-O-(malonyl)-hex, emodin-O-glc,emodin,emodin-O-glc,emodin-8-O-glc,emodin-O-(acetyl)-hex,and emodin-O-hex-sulphate.The toxic of these components require further study.Appendix A.Supplementary dataSupplementary data associated with this article can be found,in the online version,at /10.1016/j.jhazmat.2015.06. 014References[1]S.J.Song,F.F.Li,H.Yue,Z.W.Yin,Study on the anti-aging effects of radixpolygnum multiflorum,J.Hebei Med.Univ.24(2003)90–91.[2]G.Y.Lv,Z.H.Lou,S.H.Chen,H.Gu,L.T.Shan,Pharmacokinetics and tissuedistribution of2,3,5,4-tetrahydroxystilbene-2-O--glucoside from traditional Chinese medicine Polygonum multiflorum following oral administration to rats,J.Ethnopharm.137(2011)449–456.[3]L.Zhang,Y.C.Rui,Y.Qiu,T.J.Li,H.J.Liu,W.S.Chen,Expression of VEGF inendothelial cells and the effects of2,3,5,4 -tetrahydroxystilbene-2-O--d-glucoside,Acta Pharm.Sin.39(2004) 406–409.。